Intraprocedural thrombotic event during coronary intervention depends on CYP2C19 genotype and is a predictor of future clinical event

Int J Cardiol. 2015:187:231-3. doi: 10.1016/j.ijcard.2015.03.345. Epub 2015 Mar 24.

Affiliations

¹ Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
² Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Electronic address: [email protected].
³ Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Center for Clinical Pharmaceutical Sciences, Kumamoto, Japan.

PMID: 25838219
DOI: 10.1016/j.ijcard.2015.03.345

No abstract available

Keywords: Pharmacogenetics; Platelets; Polymorphism; Thrombus.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Cytochrome P-450 CYP2C19 / genetics*
Female
Genotype*
Humans
Intraoperative Complications / etiology*
Male
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use
Prognosis
Prospective Studies
Thrombosis / genetics*

Substances

Platelet Aggregation Inhibitors
Cytochrome P-450 CYP2C19